Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.
Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, Vlachojannis GJ, Jensen LO, Christiansen EH, Berencsi K, Valgimigli M, Orlandi C, Petrou M, Rapezzi C, Stone GW. Palmerini T, et al. Among authors: vlachojannis gj. J Am Coll Cardiol. 2015 Jun 16;65(23):2496-507. doi: 10.1016/j.jacc.2015.04.017. J Am Coll Cardiol. 2015. PMID: 26065988 Free article.
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial.
Vlachojannis GJ, Smits PC, Hofma SH, Togni M, Vázquez N, Valdés M, Voudris V, Puricel S, Slagboom T, Goy JJ, den Heijer P, van der Ent M. Vlachojannis GJ, et al. EuroIntervention. 2015 Jul;11(3):272-9. doi: 10.4244/EIJV11I3A53. EuroIntervention. 2015. PMID: 26196753 Free article. Clinical Trial.
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).
Smits PC, Vlachojannis GJ, McFadden EP, Royaards KJ, Wassing J, Joesoef KS, van Mieghem C, van de Ent M. Smits PC, et al. Among authors: vlachojannis gj. JACC Cardiovasc Interv. 2015 Aug 17;8(9):1157-1165. doi: 10.1016/j.jcin.2015.03.028. Epub 2015 Jul 22. JACC Cardiovasc Interv. 2015. PMID: 26210806 Free article. Clinical Trial.
Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials.
Vlachojannis GJ, Puricel S, Natsuaki M, Morimoto T, Smits PC, Kimura T. Vlachojannis GJ, et al. EuroIntervention. 2017 Mar 20;12(16):1970-1977. doi: 10.4244/EIJ-D-16-00773. EuroIntervention. 2017. PMID: 27802927 Free article. Clinical Trial.
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions.
Fam JM, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis GJ, van Geuns RJ, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi GG, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits PC, Di Mario C, Seth A, Serra A, Colombo A, Serruys P, Galassi AR, Zijlstra F, Van Mieghem NM, Diletti R. Fam JM, et al. Among authors: vlachojannis gj. EuroIntervention. 2017 Jun 20;13(3):355-363. doi: 10.4244/EIJ-D-16-00253. EuroIntervention. 2017. PMID: 28218604 Free article.
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).
Vlachojannis GJ, Smits PC, Hofma SH, Togni M, Vázquez N, Valdés M, Voudris V, Slagboom T, Goy JJ, den Heijer P, van der Ent M. Vlachojannis GJ, et al. JACC Cardiovasc Interv. 2017 Jun 26;10(12):1215-1221. doi: 10.1016/j.jcin.2017.02.029. Epub 2017 May 31. JACC Cardiovasc Interv. 2017. PMID: 28579236 Free article. Clinical Trial.
Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials.
De Luca G, Smits P, Hofma SH, Di Lorenzo E, Vlachojannis GJ, Van't Hof AWJ, van Boven AJ, Kedhi E, Stone GW, Suryapranata H; Drug-Eluting Stent in Primary Angioplasty (DESERT 3) cooperation. De Luca G, et al. Among authors: vlachojannis gj. Int J Cardiol. 2017 Oct 1;244:121-127. doi: 10.1016/j.ijcard.2017.06.022. Epub 2017 Jun 13. Int J Cardiol. 2017. PMID: 28673736 Review.
Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months).
Chevalier B, Smits PC, Carrié D, Mehilli J, Van Boven AJ, Regar E, Sawaya FJ, Chamié D, Kraaijeveld AO, Hovasse T, Vlachojannis GJ. Chevalier B, et al. Among authors: vlachojannis gj. Circ Cardiovasc Interv. 2017 Dec;10(12):e004801. doi: 10.1161/CIRCINTERVENTIONS.116.004801. Circ Cardiovasc Interv. 2017. PMID: 29246909 Free article. Clinical Trial.
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies.
Tarantini G, Masiero G, Barioli A, Paradies V, Vlachojannis G, Tellaroli P, Cortese B, di Palma G, Varricchio A, Ielasi A, Loi B, Steffenino G, Ueshima D, Mojoli M, Smits P. Tarantini G, et al. Catheter Cardiovasc Interv. 2018 Aug 1;92(2):E115-E124. doi: 10.1002/ccd.27522. Epub 2018 Mar 7. Catheter Cardiovasc Interv. 2018. PMID: 29513403
60 results